New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
07:49 EDTICPTIntercept price target raised to $525 from $360 at Oppenheimer
Oppenheimer increased its price target on Intercept after updating its valuation estimate of the company's OCA drug after positive data for the drug was reported. The firm thinks the stock could rise further as investors focus on potentially positive upcoming fibrosis data. Oppenheimer keeps an Outperform rating on the shares.
News For ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 19, 2015
16:31 EDTICPTIntercept promotes Lisa Bright to Chief Commercial & Corporate Affairs Officer
Intercept Pharmaceuticals announced that Lisa Bright has been promoted to the newly-created position of Chief Commercial and Corporate Affairs Officer. Bright joined Intercept last year from Gilead Sciences where her leadership of the European launch of Sovaldi for the treatment of chronic hepatitis C contributed to the most successful product launch in pharmaceutical history.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use